Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation
Article in Cardiovascular Diabetology (March 2023)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches
Article in Basic Research in Cardiology (January 2023)
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors
Article in Molecular Diversity (September 2022)